| 48th week of 2016 patent applcation highlights part 8 |
| Patent application number | Title | Published |
|---|
| 20160346188 | Personal Care Cleansing Composition Comprising At Least One Copolymer | 2016-12-01 |
| 20160346189 | Multi-Component Products and Multi-Step Regimens For Improving The Appearance Or Feel Of Human Skin | 2016-12-01 |
| 20160346190 | LATEX OF SPHERICAL PARTICLES WITH IMPROVED THERMAL AGEING PROPERTIES | 2016-12-01 |
| 20160346191 | ANTIOXIDANT COMPOSITIONS AND METHODS OF PROTECTING SKIN, HAIR AND NAILS AGAINST HIGH ENERGY BLUE-VIOLET LIGHT | 2016-12-01 |
| 20160346192 | NATURAL SKIN-CARE SERUM | 2016-12-01 |
| 20160346193 | Durable Skin Sanitizers Containing Water Stable Antimicrobial Silanol Quaternary Ammonium Compounds | 2016-12-01 |
| 20160346194 | BOROJO SKIN CARE PRODUCT AND USE THEREOF FOR NATURAL MOISTURIZING, ANTI-AGEING, ANTI-UV, ANTI-ANAPHYLAXIS AND WHITENING | 2016-12-01 |
| 20160346195 | PERSONAL CARE COMPOSITION CONTAINING OZONE-STRESSED YEAST LYSATES | 2016-12-01 |
| 20160346196 | PROCESS FOR MAKING CONTROLLED RELEASE MEDICAL IMPLANT PRODUCTS | 2016-12-01 |
| 20160346197 | Use of Encapsulated Cell Therapy for Treatment of Ophthalmic Disorders | 2016-12-01 |
| 20160346198 | NOVEL DISINTEGRATION SYSTEMS FOR PHARMACEUTICAL DOSAGE FORMS | 2016-12-01 |
| 20160346199 | ORALLY DISINTEGRATING TABLET COATED WITH FILM | 2016-12-01 |
| 20160346200 | NOVEL PHARMACEUTICAL FORMULATIONS | 2016-12-01 |
| 20160346201 | NANOSUSPENSION OF NATURAL MATERIALS AND PREPARATION METHOD THEREOF | 2016-12-01 |
| 20160346202 | Composition for Vectorizing an Anti-Cancer Agent | 2016-12-01 |
| 20160346203 | MEANS AND METHODS FOR OCULAR DRUG DELIVERY | 2016-12-01 |
| 20160346204 | NANOSCALE CARRIERS FOR THE DELIVERY OR CO-DELIVERY OF CHEMOTHERAPEUTICS, NUCLEIC ACIDS AND PHOTOSENSITIZERS | 2016-12-01 |
| 20160346205 | LIPOSOME LOADING | 2016-12-01 |
| 20160346206 | Assisted Particle Size Reduction Process | 2016-12-01 |
| 20160346207 | Solid Pharmaceutical Compositions Of Androgen Receptor Antagonists | 2016-12-01 |
| 20160346208 | DUAL RESPONSIVE BRAIN TARGETED NANOPARTICLES AND THEIR APPLICATIONS | 2016-12-01 |
| 20160346209 | Methods for Superdisintegrant-Based Composite Particles for Dispersion and Dissolution of Active Pharmaceutical Agents | 2016-12-01 |
| 20160346210 | MEDICAL MAGNETIC PELLETS | 2016-12-01 |
| 20160346211 | BIOERODIBLE SILICON-BASED DELIVERY VEHICLES FOR DELIVERY OF THERAPEUTIC AGENTS | 2016-12-01 |
| 20160346212 | METHOD OF DRUG FORMULATION BASED ON INCREASING THE AFFINITY OF ACTIVE AGENTS FOR CRYSTALLINE MICROPARTICLE SURFACES | 2016-12-01 |
| 20160346213 | COMPOSITE FORMULATION FOR ORAL ADMINISTRATION COMPRISING EZETIMIBE AND ROSUVASTATIN | 2016-12-01 |
| 20160346214 | TABLET FORMULATION FOR CGRP ACTIVE COMPOUNDS | 2016-12-01 |
| 20160346215 | PHARMACEUTICAL TABLET CONTAINING A LIQUID FILLED CAPSULE | 2016-12-01 |
| 20160346216 | COMPOSITION AND METHOD FOR AIDING SLEEP | 2016-12-01 |
| 20160346217 | POLYDOPAMINE-COATED CAPSULES | 2016-12-01 |
| 20160346218 | HYBRID HOLLOW MICROCAPSULE, SCAFFOLD FOR SOFT TISSUE INCLUDING SAME, AND METHODS OF PREPARING SAME | 2016-12-01 |
| 20160346219 | PHOSPHOLIPID-COATED THERAPEUTIC AGENT NANOPARTICLES AND RELATED METHODS | 2016-12-01 |
| 20160346220 | PHOSPHOLIPID-COATED THERAPEUTIC AGENT NANOPARTICLES AND RELATED METHODS | 2016-12-01 |
| 20160346221 | PHOSPHOLIPID-COATED THERAPEUTIC AGENT NANOPARTICLES AND RELATED METHODS | 2016-12-01 |
| 20160346222 | Compositions and Methods for the Delivery of Therapeutics | 2016-12-01 |
| 20160346224 | COMPOSITIONS AND METHODS FOR REDUCING VISUAL LOSS | 2016-12-01 |
| 20160346225 | METHOD OF PREPARING INGESTIBLE MULTI-SHEET UNIT HAVING PREDETERMINED FUNCTIONS AND COMBINATIONS | 2016-12-01 |
| 20160346226 | Therapeutic Applications Of Prenylated Stilbenoids Against Rotavirus Infections | 2016-12-01 |
| 20160346227 | MODIFIED AND IMMEDIATE RELEASE FORMULATIONS OF MEMANTINE | 2016-12-01 |
| 20160346228 | Use of 1-phenyl-3-dimethylaminopropane Compounds for Treating Rheumatoid Pain | 2016-12-01 |
| 20160346229 | Semisolid Aqueous Pharmaceutical Composition Containing Tapentadol | 2016-12-01 |
| 20160346230 | Endoxifen Compositions And Methods | 2016-12-01 |
| 20160346231 | Disulfiram Compositions and Treatments for Brain Tumors | 2016-12-01 |
| 20160346232 | METHODS OF TREATING PRADER-WILLI SYNDROME | 2016-12-01 |
| 20160346233 | EXTENDED RELEASE LIQUID COMPOSITIONS OF GUANFACINE | 2016-12-01 |
| 20160346234 | TREATMENT OF RESPIRATORY DISORDERS USING ROR-GAMMA INHIBITORS | 2016-12-01 |
| 20160346235 | ORAL LIQUID COMPOSITIONS OF GUANFACINE | 2016-12-01 |
| 20160346236 | COMPOSITIONS AND METHODS FOR MODULATING HEXM1 EXPRESSION | 2016-12-01 |
| 20160346237 | ACETIC ACID/THYMOL COMPOSITIONS AND THEIR USE IN THE TREATMENT OF ONYCHOMYCOSIS | 2016-12-01 |
| 20160346238 | Compositions and Methods of Use of -hydroxy--methylbutyrate (HMB) for Decreasing Fat Mass | 2016-12-01 |
| 20160346239 | HEMOSTATIC COMPOSITION AND DEVICE | 2016-12-01 |
| 20160346240 | METHODS OF CHEMOTHERAPY USING CHEMOTHERAPEUTIC AGENTS BASED ON BETA-SUBSTITUTED BETA-AMINO ACIDS AND ANALOGS | 2016-12-01 |
| 20160346241 | ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN | 2016-12-01 |
| 20160346242 | COMPOSITION COMPRISING EPA AND DHA ETHYLESTER FOR PARENTERAL ADMINISTRATION | 2016-12-01 |
| 20160346243 | DIETHYL-[6-(4-HYDROXYCARBAMOYL-PHENYL-CARBAMOYLOXY-METHYL)-NAPHTHALEN-2-YL- -METHYL]-AMMONIUM CHLORIDE FOR USE IN THE TREATMENT OF MUSCULAR DYSTROPHY | 2016-12-01 |
| 20160346244 | METAP2 INHIBITORS AND METHODS OF TREATING OBESITY | 2016-12-01 |
| 20160346245 | MAST CELL STABILIZERS TREATMENT FOR SYSTEMIC DISORDERS | 2016-12-01 |
| 20160346246 | METHODS FOR THE TREATMENT OF LUNG DISEASES WITH MAST CELL STABILIZERS | 2016-12-01 |
| 20160346247 | GELATINASE INHIBITORS AND PRODRUGS | 2016-12-01 |
| 20160346248 | Combined Acetylcholinesterase Inhibitor and Quaternary Ammonium Antimuscarinic Therapy to Alter Progression of Cognitive Diseases | 2016-12-01 |
| 20160346249 | USE OF AMITIFADINE, (+)-1-(3,4-DICHLOROPHENYL)-3-AZABICYCLO[3.1.0]HEXANE IN METHODS AND COMPOSITIONS WITH ENHANCED EFFICACY AND REDUCED METABOLIC SIDE EFFECTS AND TOXICITY FOR TREATMENT OF DEPRESSION AND OTHER CENTRAL NERVOUS SYSTEM DISORDERS AND CONDITIONS AFFECTED BY MONOAMINE NEUROTRANSMITTERS | 2016-12-01 |
| 20160346250 | METHODS FOR TREATING AND DIAGNOSING BLINDING EYE DISEASES | 2016-12-01 |
| 20160346251 | Myogenesis Promotor, Muscle Atrophy Inhibitor, Medical Composition and Taz Activator | 2016-12-01 |
| 20160346252 | NOVEL NITROIMIDAZOLE FORMULATIONS AND USES THEREOF | 2016-12-01 |
| 20160346253 | TOPICAL PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF PILONIDAL SINUS WOUNDS | 2016-12-01 |
| 20160346254 | PROTEIN KINASE INHIBITORS | 2016-12-01 |
| 20160346255 | METHODS, AGENTS AND COMPOSITIONS FOR TREATMENT OF INFLAMMATORY CONDITIONS | 2016-12-01 |
| 20160346256 | AMIDE COMPOUND AND MEDICINAL USE THEREOF | 2016-12-01 |
| 20160346257 | PHARMACEUTICAL COMPOSITIONS COMPRISING AN AROMATSE INHIBITORS | 2016-12-01 |
| 20160346258 | SOLID DISPERSIONS OF INSOLUBLE DRUG AND PREPARATION METHOD THEREOF | 2016-12-01 |
| 20160346259 | Compositions and Methods for the Treatment of Presbyopia | 2016-12-01 |
| 20160346260 | AMINOESTER DERIVATIVES | 2016-12-01 |
| 20160346261 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ADDICTION AND OTHER NEUROPSYCHIATRIC DISORDERS | 2016-12-01 |
| 20160346262 | Method of enhancing lysosomal alpha-Galactosidase A | 2016-12-01 |
| 20160346263 | CRYSTALLINE POLYMORPHS OF THE FREE BASE OF 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALD- EHYDE | 2016-12-01 |
| 20160346264 | 5-SUBSTITUTED ISOINDOLINE COMPOUNDS | 2016-12-01 |
| 20160346265 | Use of Quaternary Pyridinium Salts as Vasoprotective Agents | 2016-12-01 |
| 20160346266 | REDUCTION OR PREVENTION OF ALCOHOL REACTION WITH DIETARY SUPPLEMENTS | 2016-12-01 |
| 20160346267 | Pharmaceutical Composition Comprising Apixaban | 2016-12-01 |
| 20160346268 | AMINOESTER DERIVATIVES | 2016-12-01 |
| 20160346269 | COMBINATION THERAPY | 2016-12-01 |
| 20160346270 | BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2 | 2016-12-01 |
| 20160346271 | COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY | 2016-12-01 |
| 20160346272 | TREATMENT OF BREAST CANCER WITH LIPOSOMAL IRINOTECAN | 2016-12-01 |
| 20160346273 | METHODS FOR TREATING PRURITUS | 2016-12-01 |
| 20160346275 | PHARMACEUTICAL FORMULATIONS FOR SUSTAINED RELEASE OF SEBACOYL DINALBUPHINE ESTER | 2016-12-01 |
| 20160346276 | COMPOSITIONS AND METHODS FOR INCREASING THE METABOLIC LIFETIME OF DEXTROMETHORPHAN AND RELATED PHARMACODYNAMIC EFFECTS | 2016-12-01 |
| 20160346277 | PROCASPASE 3 ACTIVATION BY COMBINATION THERAPY | 2016-12-01 |
| 20160346278 | PARENTERAL FORMULATIONS OF LIPOPHILIC PHARMACEUTICAL AGENTS AND METHODS FOR PREPARING AND USING THE SAME | 2016-12-01 |
| 20160346279 | Histone Deacetylase 6 Selective Inhibitors for the Treatment of Cisplatin-Induced Peripheral Neuropathy | 2016-12-01 |
| 20160346280 | COMPOSITIONS AND METHODS OF TREATING PULMONARY HYPERTENSION | 2016-12-01 |
| 20160346281 | TREATMENT OF NEUROLOGICAL DISORDERS | 2016-12-01 |
| 20160346282 | METHODS AND COMPOSITIONS FOR TREATING ABNORMAL CELL GROWTH | 2016-12-01 |
| 20160346284 | SUBSTITUTED PYRAZOLOPYRIMIDINES AS GLUCOCEREBROSIDASE ACTIVATORS | 2016-12-01 |
| 20160346285 | METHODS AND KITS TO PREDICT THERAPEUTIC OUTCOME OF BTK INHIBITORS | 2016-12-01 |
| 20160346286 | Heteroaryl Substituted Pyrrolo[2,3-B] Pyridines And Pyrrolo[2,3-B] Pyrimidines As Janus Kinase Inhibitors | 2016-12-01 |
| 20160346287 | METHOD OF TREATING VIRAL INFECTIONS | 2016-12-01 |
| 20160346288 | 1-[(3-CYANO-PYRIDIN-2-YL)METHYL]-3-METHYL-7-(2-BUTYN-1-YL)-8-[3-(R)-AMINO-- PIPERIDIN-1-YL]-XANTHINE FOR THE TREATMENT OF A METABOLIC DISORDER OF A PREDOMINANTLY CARNIVOROUS NON-HUMAN ANIMAL | 2016-12-01 |
| 20160346289 | Fixed-Dose Combinations of Antiviral Compounds | 2016-12-01 |
| 20160346290 | NOVEL USE OF SIGMA-1 RECEPTOR AGONIST COMPOUNDS | 2016-12-01 |
